Kinetic Properties of a MNB/DYRK1A Mutant Suitable for the Elucidation of Biochemical Pathways-Reference-Cited by-同舟云学术

Kinetic Properties of a MNB/DYRK1A Mutant Suitable for the Elucidation of Biochemical Pathways

Published:2006-09-07 Issue:39 Volume:45 Page:12011-12019
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Adayev Tatyana¹,Chen-Hwang Mo-Chou¹,Murakami Noriko¹,Wegiel Jerzy¹,Hwang Yu-Wen¹

Affiliation:

1. Molecular Biology Department and Develomental Neurobiology Department, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York 10314

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi060632j

Reference56 articles.

1. Specificity Determinants of Substrate Recognition by the Protein Kinase DYRK1A

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microscale thermophoresis (MST) and spectral shift (SpS) in drug discovery;TrAC Trends in Analytical Chemistry;2024-07

2. EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model;European Journal of Medicinal Chemistry;2024-02

3. Development of Novel Fluorinated Polyphenols as Selective Inhibitors of DYRK1A/B Kinase for Treatment of Neuroinflammatory Diseases including Parkinson’s Disease;Pharmaceuticals;2023-03-15

4. Dual Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors: The Quest for a Disease-Modifying Treatment for Alzheimer’s Disease;Deciphering Drug Targets for Alzheimer’s Disease;2023

5. Down syndrome: a model for chromosome abnormalities;Neurobiology of Brain Disorders;2023